MHCARE-3005

METRO HEALTHCARE BERHAD

Last Price: 0.62

TTM Dividend Yield : 2.29%

Coming Quarter Report: ~ 2024-02-27

Sector: Healthcare Providers & Services

Metro Healthcare Berhad is a Malaysia based company primarily engaged in investment holding activities. The Company operates hospitals and medical services through its subsidiaries. Some of its subsidiaries are Hospital Wanita Metro (Klang), a hospital which focuses on Obstetrics & Gynecology, Pediatrics and Reproductive Medicine and Metro Maternity Kuala Selangor (Kuala Selangor), a maternal medicine facility focusing on Obstetrics & Gynecology medicine and care.

**Do feedback to us if you see any error on the data

**Data before 2015 may not be accurate

**Dividend Yield calculated base on the last price of the year

MHCARE Dividend Yield Trend

MHCARE Quarter DY Yield

Year	Financial Year	DY_Type	Announced	EX Date	Payment Date	DY($)	Yield%
2024	31/12/2024	First Interim	18/03/2024	25/03/2024	05/04/2024	0.0072	1.14
2023	31/12/2023	First Interim	08/03/2023	15/03/2023	24/03/2023	0.007	1.11
2022	31/12/2022	First Interim	30/03/2022	05/04/2022	15/04/2022	0.0066	1.05
2021	31/12/2021	First Interim	25/02/2021	04/03/2021	25/03/2021	0.0065	1.03
2020	31/12/2020	First Interim	24/02/2020	04/03/2020	02/04/2020	0.006	0.95
2019	31/12/2019	First Interim	20/06/2019	27/06/2019	10/07/2019	0.0055	0.87
2018	31/12/2018	First Interim	09/08/2018	16/08/2018	18/09/2018	0.005	0.79

MHCARE Annual DY Yield

Year	Annual DY($)	Frequency per yr	SpecialDY	Yield%
2024	0.0072	1	No	1.14
2023	0.007	1	No	1.11
2022	0.0066	1	No	1.05
2021	0.0065	1	No	1.03
2020	0.006	1	No	0.95
2019	0.0055	1	No	0.87
2018	0.005	1	No	0.79

MHCARE Quarter Report History

Q Date	Announced	Revenue	P/L	EPS	Margin	QoQ%	YoY%
30/06/2024	29/08/2024	24,500,000	3,500,000.00	0.57	14.29	16.67	34.62
31/12/2023	23/02/2024	23,000,000	3,000,000.00	0.49	13.04	-9.09	-40.00
30/06/2023	22/08/2023	21,700,000	3,300,000.00	0.53	15.21	32.00	-25.00
31/12/2022	27/02/2023	20,800,000	2,500,000.00	0.40	12.02	-3.85	-28.57
30/06/2022	30/08/2022	19,500,000	2,600,000.00	0.43	13.33	-48.00	36.84
31/12/2021	22/02/2022	21,400,000	5,000,000.00	1.71	23.36	13.64	316.67
30/06/2021	26/08/2021	20,800,000	4,400,000.00	2.13	21.15	25.71	300.00
31/12/2020	22/02/2021	17,200,000	3,500,000.00	1.74	20.35	84.21	191.67
30/06/2020	18/08/2020	11,100,000	1,900,000.00	0.95	17.12	58.33	191.86
31/12/2019	20/02/2020	11,700,000	1,200,000.00	0.62	10.26	9.09	-20.00

MHCARE Quarter Profit Trend

MHCARE Annual Profit Trend

Cash Flow

In financial accounting, operating cash flow (OCF), cash flow provided by operations, cash flow from operating activities (CFO) or free cash flow from operations (FCFO), refers to the amount of cash a company generates from the revenues it brings in, excluding costs associated with long – term investment on capital items or investment in securities.(From Wiki)

MHCARE Annual Cash Flow

ROE & Payout Ratio

Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholders’ equity. Because shareholders’ equity is equal to a company’s assets minus its debt, ROE is considered the return on net assets. ROE is considered a measure of the profitability of a corporation in relation to stockholders’ equity. (From Investopedia)

The payout ratio is a financial metric showing the proportion of earnings a company pays its shareholders in the form of dividends, expressed as a percentage of the company’s total earnings. On some occasions, the payout ratio refers to the dividends paid out as a percentage of a company’s cash flow. The payout ratio is also known as the dividend payout ratio. (From Investopedia)

MHCARE Annual ROE & Payout Ratio

0 Comments

VictorFoo November 3, 2021 at 4:25 pm

Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia.

Dividends.my

Malaysia Dividends Ranking Website